← All organizations

Institut de la Macula y la Retina

Academic/Hospital

Also known as: Institut de la Macula | Institut de la Macula i de la Retina | Institut de la Macula y la Retina

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

Dec 2, 2020

Timeline

No events for the selected filters.

Drugs by trial phase (9 distinct, 3 trials)

Phase 4 (1 own, 0 via acquisition)

ranibizumab

Other trials (8 own, 0 via acquisition)

Indications

Studied for

Recent trials (7)

NCT05056025Overall official - principal investigatorN/ADec 2, 2020
NCT05056025Reponsible party - principal investigatorN/ADec 2, 2020
NCT05056025Lead sponsorN/ADec 2, 2020
NCT05391074Lead sponsorN/ADec 1, 2020
NCT01500915Reponsible party - principal investigatorPhase 4Nov 1, 2010
NCT01500915Overall official - principal investigatorPhase 4Nov 1, 2010
NCT01500915Lead sponsorPhase 4Nov 1, 2010

Details

Last known activity: Dec 2, 2020